Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Videos

Companies

Press Releases

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Resource

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Tech

Life Science

phase 2 clinical trial

Catabasis to Evaluate Muscular Dystrophy Treatment

pharmaceutical investing

Cytokinetics Starts Phase 2 Clinical Trial for Cardiomyopathy Treatment

BioXcel Therapeutics to Expand BXCL701 Study

Mustang Bio Announces Additional Clinical Data on MB-107

Cara Therapeutics Tumbles on Phase 2 Oral KORSUVA Results

pharmaceutical investing

Rafael Pharmaceuticals Expands Phase 2 CPI-613 Trial

pharmaceutical investing

Verrica Pharmaceuticals Dips on FDA IND Acceptance

Bio-Path Holdings Completes Safety Testing Study in Stage 2 of Phase 2 Trial

Anchiano Discontinues Phase 2 Codex Study

AzurRx BioPharma Announces Positive Phase 2 Trial Results of MS1819

XORTX Reports Positive Phase 2 Results in Type 2 Diabetic Nephorpathy

pharmaceutical investing

Foamix Enrolls First Patient in Phase 2 Acne Clinical Trial

Aduro Biotech Doses First Patient in Phase 2 Study of ADU-S100

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial

pharmaceutical investing

Investing News NetworkYour trusted source for investing success

phase 2 clinical trial

Catabasis to Evaluate Muscular Dystrophy Treatment

Cytokinetics Starts Phase 2 Clinical Trial for Cardiomyopathy Treatment

BioXcel Therapeutics to Expand BXCL701 Study

Mustang Bio Announces Additional Clinical Data on MB-107

Cara Therapeutics Tumbles on Phase 2 Oral KORSUVA Results

Rafael Pharmaceuticals Expands Phase 2 CPI-613 Trial

Verrica Pharmaceuticals Dips on FDA IND Acceptance

Bio-Path Holdings Completes Safety Testing Study in Stage 2 of Phase 2 Trial

Anchiano Discontinues Phase 2 Codex Study

AzurRx BioPharma Announces Positive Phase 2 Trial Results of MS1819

XORTX Reports Positive Phase 2 Results in Type 2 Diabetic Nephorpathy

Foamix Enrolls First Patient in Phase 2 Acne Clinical Trial

Aduro Biotech Doses First Patient in Phase 2 Study of ADU-S100

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial

Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat

Latest News

Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Charbone Hydrogen Announces Q1 2025 Financial Results

Charbone Hydrogene annonce les resultats financiers T1 2025

CDX May Investor Presentation